Revisions for Evaluating the Safety and Efficacy of Deucravacitinib Compared to Placebo Hidradenitis Suppurativa (HS).
Primary tabs
Revision | Operations |
---|---|
08/18/2023 - 22:45 by Alicanto Admin | Current revision |
Revision | Operations |
---|---|
08/18/2023 - 22:45 by Alicanto Admin | Current revision |